LobbyingAccu Reference Medical Lab lobbying by quarter
Accu Reference Medical Lab's latest lobbying report covers Q2 2026, at $80K. The four quarters Q4 2025–Q3 2026 total $230K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Accu Reference Medical Lab
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $230K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $60K | 1 |
| Q1 2023 | $60K | 1 |
| Q2 2023 | $60K | 1 |
| Q3 2023 | $60K | 1 |
| Q4 2023 | $60K | 1 |
| Q1 2024 | $60K | 1 |
| Q2 2024 | $60K | 1 |
| Q3 2024 | $60K | 1 |
| Q4 2024 | $60K | 1 |
| Q1 2025 | $65K | 1 |
| Q2 2025 | $75K | 1 |
| Q3 2025 | $75K | 1 |
| Q4 2025 | $75K | 1 |
| Q1 2026 | $75K | 1 |
| Q2 2026 | $80K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$985K · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Federal Trade Commission (FTC)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Carmen Group | $985K | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Carmen Group | $80K |
| 04/20for Q1 | Carmen Group | $75K |
| 01/20for Q4 2025 | Carmen Group | $75K |
| 25/10/21for Q3 2025 | Carmen Group | $75K |
| 25/07/17for Q2 2025 | Carmen Group | $75K |
| 25/04/15for Q1 2025 | Carmen Group | $65K |
| 25/01/16for Q4 2024 | Carmen Group | $60K |
| 24/10/21for Q3 2024 | Carmen Group | $60K |
| 24/07/22for Q2 2024 | Carmen Group | $60K |
| 24/04/22for Q1 2024 | Carmen Group | $60K |
| 24/01/22for Q4 2023 | Carmen Group | $60K |
| 23/10/19for Q3 2023 | Carmen Group | $60K |
| 23/07/19for Q2 2023 | Carmen Group | $60K |
| 23/04/19for Q1 2023 | Carmen Group | $60K |
| 23/01/19for Q4 2022 | Carmen Group | $60K |